Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 368

1.

Adaptation of host transmission cycle during Clostridium difficile speciation.

Kumar N, Browne HP, Viciani E, Forster SC, Clare S, Harcourt K, Stares MD, Dougan G, Fairley DJ, Roberts P, Pirmohamed M, Clokie MRJ, Jensen MBF, Hargreaves KR, Ip M, Wieler LH, Seyboldt C, Norén T, Riley TV, Kuijper EJ, Wren BW, Lawley TD.

Nat Genet. 2019 Aug 12. doi: 10.1038/s41588-019-0478-8. [Epub ahead of print]

PMID:
31406348
2.

Characterization of Clostridioides difficile isolates recovered from hospitalized patients and the hospitals environment and air: A multicenter study.

Aliramezani A, Talebi M, Golbabaei F, Baghani A, Marjani M, Afhami S, Hajabdolbaghi M, Boroumand MA, Kuijper EJ, Douraghi M.

Anaerobe. 2019 Jun 25;59:154-158. doi: 10.1016/j.anaerobe.2019.06.012. [Epub ahead of print]

PMID:
31247292
3.

[Relapsing fever after travelling in the tropics; a story with a twist].

Lambregts MMC, Bentvelsen RG, Makiello PE, de Wever B, Kuijper EJ, Visser LG.

Ned Tijdschr Geneeskd. 2019 May 31;163. pii: D3455. Dutch.

PMID:
31187963
4.

Treatment of (recurrent) Clostridioides difficile Infections in Children and Adults.

Kuijper EJ, Coia JE, Vehreschild MJGT, Keller J, Terveer L.

J Pediatr Gastroenterol Nutr. 2019 Aug;69(2):e57-e58. doi: 10.1097/MPG.0000000000002387. No abstract available.

PMID:
31169660
5.

Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.

Ducarmon QR, Zwittink RD, Hornung BVH, van Schaik W, Young VB, Kuijper EJ.

Microbiol Mol Biol Rev. 2019 Jun 5;83(3). pii: e00007-19. doi: 10.1128/MMBR.00007-19. Print 2019 Aug 21. Review.

PMID:
31167904
6.

Identification and validation of two peptide markers for the recognition of Clostridioides difficile MLST-1 and MLST-11 by MALDI-MS.

Corver J, Sen J, Hornung BVH, Mertens BJ, Berssenbrugge EKL, Harmanus C, Sanders IMJG, Kumar N, Lawley TD, Kuijper EJ, Hensbergen PJ, Nicolardi S.

Clin Microbiol Infect. 2019 Jul;25(7):904.e1-904.e7. doi: 10.1016/j.cmi.2018.10.008. Epub 2018 Oct 26.

PMID:
31130255
7.

Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial.

Groeneveld GH, van der Reyden TJ, Joosten SA, Bootsma HJ, Cobbaert CM, de Vries JJC, Kuijper EJ, van Dissel JT.

J Antimicrob Chemother. 2019 Aug 1;74(8):2385-2393. doi: 10.1093/jac/dkz207.

8.

Spread of ESBL-producing Escherichia coli in nursing home residents in Ireland and the Netherlands may reflect infrastructural differences.

Terveer EM, Fallon M, Kraakman MEM, Ormond A, Fitzpatrick M, Caljouw MAA, Martin A, van Dorp SM, Wong MC, Kuijper EJ, Fitzpatrick F.

J Hosp Infect. 2019 May 9. pii: S0195-6701(19)30195-1. doi: 10.1016/j.jhin.2019.05.003. [Epub ahead of print]

PMID:
31077778
9.

Issues and current standards of controls in microbiome research.

Hornung BVH, Zwittink RD, Kuijper EJ.

FEMS Microbiol Ecol. 2019 May 1;95(5). pii: fiz045. doi: 10.1093/femsec/fiz045.

10.

Manipulation of the microbiota to eradicate multidrug-resistant Enterobacteriaceae from the human intestinal tract.

Kuijper EJ, Vendrik KEW, Vehreschild MJGT.

Clin Microbiol Infect. 2019 Jul;25(7):786-789. doi: 10.1016/j.cmi.2019.03.025. Epub 2019 Apr 6. No abstract available.

PMID:
30965098
11.

Relevance of heterokaryosis for adaptation and azole-resistance development in Aspergillus fumigatus.

Zhang J, Snelders EE, Zwaan BJ, Schoustra SE, Kuijper EJ, Arendrup MC, Melchers WJG, Verweij PE, Debets AJM.

Proc Biol Sci. 2019 Feb 13;286(1896):20182886. doi: 10.1098/rspb.2018.2886.

PMID:
30963936
12.

Response to: 'Circulating microbiome in blood of different circulatory compartments' by Schierwagen et al.

Hornung BVH, Zwittink RD, Ducarmon QR, Kuijper EJ.

Gut. 2019 Apr 6. pii: gutjnl-2019-318601. doi: 10.1136/gutjnl-2019-318601. [Epub ahead of print] No abstract available.

PMID:
30954950
13.

Clostridium difficile infection: review.

Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, Goldman S, Wultańska D, Garlicki A, Biesiada G.

Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1211-1221. doi: 10.1007/s10096-019-03539-6. Epub 2019 Apr 3. Review.

14.

Evaluation of the Liat Cdiff Assay for Direct Detection of Clostridioides difficile Toxin Genes within 20 Minutes.

Hetem DJ, Bos-Sanders I, Nijhuis RHT, Tamminga S, Berlinger L, Kuijper EJ, Sickler JJ, Claas ECJ.

J Clin Microbiol. 2019 May 24;57(6). pii: e00416-19. doi: 10.1128/JCM.00416-19. Print 2019 Jun.

15.

Detection of Clostridium difficile in the environment in a veterinary teaching hospital.

Villagómez-Estrada S, Blanco JL, Melo-Duran D, Martín C, Harmanus C, Kuijper EJ, García ME.

Anaerobe. 2019 Jun;57:55-58. doi: 10.1016/j.anaerobe.2019.03.011. Epub 2019 Mar 18.

PMID:
30898637
16.

Fifty shades of graft: How to improve the efficacy of faecal microbiota transplantation for decolonization of antibiotic-resistant bacteria.

Davido B, Batista R, Dinh A, de Truchis P, Terveer EM, Roberts B, Kuijper EJ, Caballero S.

Int J Antimicrob Agents. 2019 May;53(5):553-556. doi: 10.1016/j.ijantimicag.2019.03.008. Epub 2019 Mar 14.

PMID:
30880228
17.

Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands.

Gast KB, van der Hoeven A, de Boer MGJ, van Esser JWJ, Kuijper EJ, Verweij JJ, van Keulen PHJ, van der Beek MT.

Med Mycol Case Rep. 2019 Jan 14;24:5-8. doi: 10.1016/j.mmcr.2019.01.005. eCollection 2019 Jun.

18.

Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation.

Bekker V, Zwittink RD, Knetsch CW, Sanders IMJG, Berghuis D, Heidt PJ, Vossen JMJJ, de Vos WM, Belzer C, Bredius RGM, Van't Hof PJ, Lankester AC, Kuijper EJ.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1164-1171. doi: 10.1016/j.bbmt.2019.01.037. Epub 2019 Feb 5.

PMID:
30731251
19.

ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.

Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, Schwaber MJ, Souli M, Torre-Cisneros J, Price JR, Rodríguez-Baño J.

Clin Microbiol Infect. 2019 Jul;25(7):807-817. doi: 10.1016/j.cmi.2019.01.005. Epub 2019 Jan 29.

20.

Segmental induction heating of orthopaedic metal implants.

Pijls BG, Sanders IMJG, Kuijper EJ, Nelissen RGHH.

Bone Joint Res. 2018 Dec 1;7(11):609-619. doi: 10.1302/2046-3758.711.BJR-2018-0080.R1. eCollection 2018 Nov.

21.

Characterization of the virulence of a non-RT027, non-RT078 and binary toxin-positive Clostridium difficile strain associated with severe diarrhea.

Li C, Harmanus C, Zhu D, Meng X, Wang S, Duan J, Liu S, Fu C, Zhou P, Liu R, Wu A, Kuijper EJ, Smits WK, Fu L, Sun X.

Emerg Microbes Infect. 2018 Dec 12;7(1):211. doi: 10.1038/s41426-018-0211-1.

22.

Genome Location Dictates the Transcriptional Response to PolC Inhibition in Clostridium difficile.

van Eijk E, Boekhoud IM, Kuijper EJ, Bos-Sanders IMJG, Wright G, Smits WK.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01363-18. doi: 10.1128/AAC.01363-18. Print 2019 Feb.

23.

Clinical Application and Potential of Fecal Microbiota Transplantation.

Ooijevaar RE, Terveer EM, Verspaget HW, Kuijper EJ, Keller JJ.

Annu Rev Med. 2019 Jan 27;70:335-351. doi: 10.1146/annurev-med-111717-122956. Epub 2018 Nov 7.

PMID:
30403550
25.

Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD).

de Jonge E, de Wilde RBP, Juffermans NP, Oostdijk EAN, Bernards AT, van Essen EHR, Kuijper EJ, Visser CE, Kesecioglu J, Bonten MJM.

Crit Care. 2018 Sep 29;22(1):243. doi: 10.1186/s13054-018-2170-2.

26.

Spatial clustering and livestock exposure as risk factor for community-acquired Clostridium difficile infection.

van Dorp SM, Hensgens MPM, Dekkers OM, Demeulemeester A, Buiting A, Bloembergen P, de Greeff SC, Kuijper EJ.

Clin Microbiol Infect. 2019 May;25(5):607-612. doi: 10.1016/j.cmi.2018.07.018. Epub 2018 Aug 2.

PMID:
30076972
27.

Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection.

Förster B, Chung PK, Crobach MJT, Kuijper EJ.

Front Microbiol. 2018 Jun 25;9:1382. doi: 10.3389/fmicb.2018.01382. eCollection 2018. Review.

28.

Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections.

Baktash A, Terveer EM, Zwittink RD, Hornung BVH, Corver J, Kuijper EJ, Smits WK.

Front Microbiol. 2018 Jun 12;9:1242. doi: 10.3389/fmicb.2018.01242. eCollection 2018. Review.

29.

Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans.

Fleurbaaij F, Henneman AA, Corver J, Knetsch CW, Smits WK, Nauta ST, Giera M, Dragan I, Kumar N, Lawley TD, Verhoeven A, van Leeuwen HC, Kuijper EJ, Hensbergen PJ.

Sci Rep. 2018 May 25;8(1):8181. doi: 10.1038/s41598-018-26079-z.

30.

Understanding Clostridium difficile Colonization.

Crobach MJT, Vernon JJ, Loo VG, Kong LY, Péchiné S, Wilcox MH, Kuijper EJ.

Clin Microbiol Rev. 2018 Mar 14;31(2). pii: e00021-17. doi: 10.1128/CMR.00021-17. Print 2018 Apr. Review.

31.

The pitfalls of laboratory diagnostics of Clostridium difficile infection.

Krutova M, Wilcox MH, Kuijper EJ.

Clin Microbiol Infect. 2018 Jul;24(7):682-683. doi: 10.1016/j.cmi.2018.02.026. Epub 2018 Mar 2. Review. No abstract available.

32.

Guidance document for prevention of Clostridium difficile infection in acute healthcare settings.

Tschudin-Sutter S, Kuijper EJ, Durovic A, Vehreschild MJGT, Barbut F, Eckert C, Fitzpatrick F, Hell M, Norèn T, O'Driscoll J, Coia J, Gastmeier P, von Müller L, Wilcox MH, Widmer AF; Committee.

Clin Microbiol Infect. 2018 Oct;24(10):1051-1054. doi: 10.1016/j.cmi.2018.02.020. Epub 2018 Mar 2. Review.

PMID:
29505879
33.

The ESCMID Study Group for Clostridium difficile: History, Role and Perspectives.

Coia JE, Kuijper EJ.

Adv Exp Med Biol. 2018;1050:245-254. doi: 10.1007/978-3-319-72799-8_14. Review.

PMID:
29383673
34.

Diagnostic Guidance for C. difficile Infections.

Crobach MJT, Baktash A, Duszenko N, Kuijper EJ.

Adv Exp Med Biol. 2018;1050:27-44. doi: 10.1007/978-3-319-72799-8_3. Review.

PMID:
29383662
35.

Update of treatment algorithms for Clostridium difficile infection.

Ooijevaar RE, van Beurden YH, Terveer EM, Goorhuis A, Bauer MP, Keller JJ, Mulder CJJ, Kuijper EJ.

Clin Microbiol Infect. 2018 May;24(5):452-462. doi: 10.1016/j.cmi.2017.12.022. Epub 2018 Jan 6. Review.

36.

Ribotype 078 Clostridium difficile infection incidence in Dutch hospitals is not associated with provincial pig farming: Results from a national sentinel surveillance, 2009-2015.

van Dorp SM, de Greeff SC, Harmanus C, Sanders IMJG, Dekkers OM, Knetsch CW, Kampinga GA, Notermans DW, Kuijper EJ.

PLoS One. 2017 Dec 29;12(12):e0189183. doi: 10.1371/journal.pone.0189183. eCollection 2017.

37.

How to: Surveillance of Clostridium difficile infections.

Krutova M, Kinross P, Barbut F, Hajdu A, Wilcox MH, Kuijper EJ; survey contributors.

Clin Microbiol Infect. 2018 May;24(5):469-475. doi: 10.1016/j.cmi.2017.12.008. Epub 2017 Dec 20. Review.

38.

Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans.

Knetsch CW, Kumar N, Forster SC, Connor TR, Browne HP, Harmanus C, Sanders IM, Harris SR, Turner L, Morris T, Perry M, Miyajima F, Roberts P, Pirmohamed M, Songer JG, Weese JS, Indra A, Corver J, Rupnik M, Wren BW, Riley TV, Kuijper EJ, Lawley TD.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01384-17. doi: 10.1128/JCM.01384-17. Print 2018 Mar.

39.

Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.

Crobach MJT, Duszenko N, Terveer EM, Verduin CM, Kuijper EJ.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01316-17. doi: 10.1128/JCM.01316-17. Print 2018 Mar.

40.

[Faecal microbiota transplantation: indications in perspective].

van Beurden YH, Terveer EM, Keller JJ, Kuijper EJ, Mulder CJJ, Vandenbroucke-Grauls CMJE.

Ned Tijdschr Geneeskd. 2017;161:D1623. Review. Dutch.

PMID:
29076444
41.

An outbreak of Clostridium difficile infections due to new PCR ribotype 826: epidemiologic and microbiologic analyses.

Crobach MJT, Voor In 't Holt AF, Knetsch CW, van Dorp SM, Bras W, Harmanus C, Kuijper EJ, Vos MC.

Clin Microbiol Infect. 2018 Mar;24(3):309.e1-309.e4. doi: 10.1016/j.cmi.2017.08.014. Epub 2017 Aug 19.

42.

Prevalence and risk factors for colonization of Clostridium difficile among adults living near livestock farms in the Netherlands.

Zomer TP, VAN Duijkeren E, Wielders CCH, Veenman C, Hengeveld P, VAN DER Hoek W, DE Greeff SC, Smit LAM, Heederik DJ, Yzermans CJ, Kuijper EJ, Maassen CBM.

Epidemiol Infect. 2017 Oct;145(13):2745-2749. doi: 10.1017/S0950268817001753. Epub 2017 Aug 14.

PMID:
28805171
43.

Data from a survey of Clostridium perfringens and Clostridium difficile shedding by dogs and cats in the Madrid region (Spain), including phenotypic and genetic characteristics of recovered isolates.

Álvarez-Pérez S, Blanco JL, Harmanus C, Kuijper EJ, García ME.

Data Brief. 2017 Jul 15;14:88-100. doi: 10.1016/j.dib.2017.07.029. eCollection 2017 Oct.

44.

[Gastrointestinal symptoms with meningococcal infection. Emergence of Neisseria meningitidis serogroup W.]

Wunderink HF, Vlasveld IN, Knol MJ, van der Ende A, van Essen EHR, Kuijper EJ.

Ned Tijdschr Geneeskd. 2017;161:D1456. Dutch.

PMID:
28745253
45.

Prevalence and characteristics of Clostridium perfringens and Clostridium difficile in dogs and cats attended in diverse veterinary clinics from the Madrid region.

Álvarez-Pérez S, Blanco JL, Harmanus C, Kuijper EJ, García ME.

Anaerobe. 2017 Dec;48:47-55. doi: 10.1016/j.anaerobe.2017.06.023. Epub 2017 Jul 5.

PMID:
28687280
46.

Recreational sandboxes for children and dogs can be a source of epidemic ribotypes of Clostridium difficile.

Orden C, Neila C, Blanco JL, Álvarez-Pérez S, Harmanus C, Kuijper EJ, García ME.

Zoonoses Public Health. 2018 Feb;65(1):88-95. doi: 10.1111/zph.12374. Epub 2017 Jul 7.

PMID:
28686001
47.

Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015.

Krutova M, Matejkova J, Drevinek P, Kuijper EJ, Nyc O; study group.

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2251-2258. doi: 10.1007/s10096-017-3055-z. Epub 2017 Jul 5.

PMID:
28681203
48.

Effectiveness of various cleaning and disinfectant products on Clostridium difficile spores of PCR ribotypes 010, 014 and 027.

Kenters N, Huijskens EGW, de Wit SCJ, Sanders IGJM, van Rosmalen J, Kuijper EJ, Voss A.

Antimicrob Resist Infect Control. 2017 Jun 3;6:54. doi: 10.1186/s13756-017-0210-3. eCollection 2017.

49.

The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.

Krutova M, Nyc O, Matejkova J, Kuijper EJ, Jalava J, Mentula S.

J Microbiol Immunol Infect. 2018 Jun;51(3):344-351. doi: 10.1016/j.jmii.2017.02.002. Epub 2017 May 24.

50.

Prevalence of colistin resistance gene (mcr-1) containing Enterobacteriaceae in feces of patients attending a tertiary care hospital and detection of a mcr-1 containing, colistin susceptible E. coli.

Terveer EM, Nijhuis RHT, Crobach MJT, Knetsch CW, Veldkamp KE, Gooskens J, Kuijper EJ, Claas ECJ.

PLoS One. 2017 Jun 2;12(6):e0178598. doi: 10.1371/journal.pone.0178598. eCollection 2017.

Supplemental Content

Loading ...
Support Center